Crossref
Hide and Seq: Using Personalized Circulating Tumor DNA Sequencing for Measurable Residual Disease Detection in Acute Myeloid Leukemia
The Hematologist · 01.11.2026 · 23 (6)
DOI: 10.1182/hem.v23.6.202667 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Hematologist, online erschienen am 26.10.2026. Verfasst von Ritika Dutta und 1 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Dutta, R., & Muffly, L. (2026). Hide and Seq: Using Personalized Circulating Tumor DNA Sequencing for Measurable Residual Disease Detection in Acute Myeloid Leukemia. The Hematologist, 23(6). https://doi.org/10.1182/hem.v23.6.202667
Vancouver
Dutta R, Muffly L. Hide and Seq: Using Personalized Circulating Tumor DNA Sequencing for Measurable Residual Disease Detection in Acute Myeloid Leukemia. The Hematologist. 2026;23(6). doi:10.1182/hem.v23.6.202667
BibTeX
@article{Dutta2026,
author = {Dutta, Ritika and Muffly, Lori},
title = {Hide and Seq: Using Personalized Circulating Tumor DNA Sequencing for Measurable Residual Disease Detection in Acute Myeloid Leukemia},
journal = {The Hematologist},
year = {2026},
volume = {23},
number = {6},
doi = {10.1182/hem.v23.6.202667}
}
EUVIMED